Cargando…
CD20(+) tumor‐infiltrating immune cells and CD204(+) M2 macrophages are associated with prognosis in thymic carcinoma
Thymic carcinoma is a rare malignant disease with no standard systemic chemotherapy. The purpose of the present study was to investigate tumor‐infiltrating immune cells (TIIC) in the tumor microenvironment (TME), focusing on the impact of TIIC and program death‐ligand 1 (PD‐L1) expression on clinica...
Autores principales: | Sato, Jun, Kitano, Shigehisa, Motoi, Noriko, Ino, Yoshinori, Yamamoto, Noboru, Watanabe, Shunichi, Ohe, Yuichiro, Hiraoka, Nobuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293080/ https://www.ncbi.nlm.nih.gov/pubmed/32277550 http://dx.doi.org/10.1111/cas.14409 |
Ejemplares similares
-
Tumor‐associated CD204(+) M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma
por: Kawachi, Asuka, et al.
Publicado: (2018) -
CD8-positive T cells and CD204-positive M2-like macrophages predict postoperative prognosis of very high-risk prostate cancer
por: Yanai, Yoshinori, et al.
Publicado: (2021) -
Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment
por: Shirasawa, Masayuki, et al.
Publicado: (2020) -
Reliable evaluation of tumor-infiltrating lymphocytes in pancreatic cancer tissue biopsies
por: Ino, Yoshinori, et al.
Publicado: (2019) -
Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma
por: Katsuya, Yuki, et al.
Publicado: (2023)